New Crambescidin-Type Alkaloids from the Indonesian Marine Sponge Clathria Bulbotoxa
Total Page:16
File Type:pdf, Size:1020Kb
marine drugs Article New Crambescidin-Type Alkaloids from the Indonesian Marine Sponge Clathria bulbotoxa Kasmiati Kasmiati 1,2, Yukio Yoshioka 3, Tetsuji Okamoto 3 and Makoto Ojika 1,* ID 1 Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa-ku, Nagoya 464-8601, Japan; [email protected] 2 Faculty of Marine Science and Fishery, Hasanuddin University, Jalan Perintis Kemerdekaan KM. 10, Makassar 90245, Indonesia 3 Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima 734-8553, Japan; [email protected] (Y.Y.); [email protected] (T.O.) * Correspondence: [email protected]; Tel.: +81-52-789-4116 Received: 16 February 2018; Accepted: 5 March 2018; Published: 8 March 2018 Abstract: A crude methanolic extract of the Indonesian sponge Clathria bulbotoxa showed a potent cytotoxic activity against the human epidermoid carcinoma A431 cells. An investigation of the active components led to the isolation of three new compounds named crambescidins 345 (1), 361 (2), and 373 (3), together with the known related metabolites crambescidins 359 (4), 657 (5), and 800 (6). The structures of the compounds were determined by spectroscopic analysis. These compounds 1–4 that possess a simple pentacyclic guanidine core exhibited moderate cytotoxicity against the A431 cells with the IC50 values of 7.0, 2.5, 0.94, and 3.1 µM, respectively, while the known compounds 5 and 6 that possess a long aliphatic side chain were found to be significantly cytotoxic. On the other hand, in an anti-oomycete activity test against the fungus-like plant pathogen Phytophthora capsici, 1–4 showed a higher activity than that of 5 and 6, suggesting that the long aliphatic side chain plays a significant role for cytotoxicity, but is not effective or suppressive for anti-oomycete activity. Keywords: Indonesian sponge; Clathria bulbotoxa; crambescidin; cytotoxicity; anti-oomycete activity 1. Introduction Marine sponges (phyla Porifera) are one of the most prolific and the largest sources of novel bioactive compounds among marine organisms [1,2], with more than 200 new compounds reported each year [3]. During the last decade from 2001 to 2010, approximately 2400 new natural products had been discovered from 671 species of sponges, contributing 29% of the marine natural products reported within the period [4]. Ecological studies reported that sponges produce a wide array of secondary metabolites for defensive purposes to protect them from threats of competitors, predators, and pathogens [5,6]. Furthermore, sponges are frequently a host for microbial symbionts, which are regarded as one of the most important sources of bioactive molecules [7]. Studies on Indonesian marine sponges are interesting because Indonesia is the largest archipelagic country in the world, encompassing approximately 86,700 square kilometers of coral reef ecosystems [8], which are important for sponges as the most dominant benthic inhabiting coral reefs [9]. The Indonesian coral reefs are located in the coral triangle area, which is the global center of marine biodiversity and is recognized as the richest region on the earth [10]. Therefore, sponges from the coral ecosystems produce metabolites with various biological properties and become a target of continuing searching for new bioactive compounds [11,12]. Mar. Drugs 2018, 16, 84; doi:10.3390/md16030084 www.mdpi.com/journal/marinedrugs Mar. Drugs 2018, 16, x FOR PEER REVIEW 2 of 13 Mar. Drugs 2018, 16, 84 2 of 13 We recently investigated the biological activity of extracts from Indonesian marine organisms, includingWe recentlysix sponge investigated species (Agelas the biologicalconifera, Carteriospongia activity of foliascens extracts, fromClathria Indonesian bulbotoxa, Clathria marine organisms,reinwardti, Haliclona including koromella six sponge, and species Tedania (Agelas ignis conifera), and, Carteriospongiafound that an foliascens extract ,ofClathria the sponge bulbotoxa C., Clathriabulbotoxa reinwardti was highly, Haliclona cytotoxic. koromella The ,sponges and Tedania of the ignis genus), and Clathria found thatare anwidely extract distributed of the sponge in theC. bulbotoxatropical shallowwas highly waters cytotoxic. and temperate The sponges regions, of the especially genus Clathria along arethe widelycost of distributedthe southern in hemisphere the tropical shallow[13,14]. This waters genus and has temperate been recognized regions, especially as an excellent along the producer cost of theof novel southern secondary hemisphere metabolites [13,14]. Thisexhibiting genus diverse has been chemical recognized structures as an excellentincluding producer alkaloids of[15–20], novel secondarycarotenoids metabolites [21,22], peptides exhibiting [23], diversesugars [24], chemical terpenoids structures [25,26], including and sterols alkaloids [27–29]. [15– 20 ], carotenoids [21,22], peptides [23], sugars [24], terpenoidsFor the [25 above,26], and reasons sterols as [27 well–29]. as the abundant population of the Clathria bulbotoxa in the SamalonaFor the Island, above reasonsSouth asSulawesi well as theSea, abundant we were population interested of thein Clathriathe investigation bulbotoxa in theof Samalonabioactive Island,compounds South from Sulawesi this sponge, Sea, we leading were interested to the isol ination the investigationof three new ofcrambescidin-type bioactive compounds guanidine from thisalkaloids sponge, 1–3 leading as well to theas isolationthree known of three related new crambescidin-typeproducts 4–6. Herein, guanidine we present alkaloids the1 –isolation,3 as well asstructure three known elucidation, related and products biological4– 6characterization. Herein, we present of these the guanidine isolation, alkaloids. structure elucidation, and biological characterization of these guanidine alkaloids. 2. Results and Discussion 2. Results and Discussion 2.1. Isolation and Structural Elucidation 2.1. Isolation and Structural Elucidation The MeOH extract of the freeze-dried sponge was found to be higly cytotoxic against the humanThe epidermoid MeOH extract carcinoma of the freeze-dried cell line spongeA431 at was an foundIC50 value to be higlyof 0.046 cytotoxic μg/mL against and theto humanexhibit epidermoidanti-oomycete carcinoma activity against cell line the A431 fungus-like at an IC50 plantvalue pathogen of 0.046 µ g/mLPhytophthora and to capsici exhibit at anti-oomycete a dose of 50 activityμg/disk. against The active the fungus-like extract was plant subjected pathogen to Phytophthorabioassay-guided capsici fractionation,at a dose of 50followedµg/disk. by The the active final extractreversed-phase was subjected high performance to bioassay-guided liquid chro fractionation,matography followed (HPLC) byto yield the final six compounds reversed-phase 1–6. high The performancecompounds 4 liquid–6 were chromatography identified as (HPLC)crambescidins to yield six359compounds [30], 657 [31],1–6. Theand compounds800 [32] (Figure4–6 were 1), identifiedrespectively, as crambescidinsby comparison 359 with [30 ],published 657 [31], andspectroscopic 800 [32] (Figure data,1 ),whereas respectively, the compounds by comparison 1–3 withwere publishedfound to be spectroscopic new crambescidin data, whereas analogs. the compounds 1–3 were found to be new crambescidin analogs. Figure 1. Chemical structures of 1–6. Crambescidin 345 (1) possesses the molecular formula of C20H31N3O2 deduced from a high Crambescidin 345 (1) possesses the molecular formula of C H N O deduced from a high resolution electrospry ionization mass spectrum (HR-ESIMS) using20 the31 pseudo-molecular3 2 ion at m/z resolution electrospry ionization mass spectrum (HR-ESIMS) using the pseudo-molecular ion at m/z 346.2495 [M + H]+ (calculated for C20H32N3O2 346.2489). The infra red (IR) spectrum of 1 exhibited a 346.2495 [M + H]+ (calculated for C H N O 346.2489). The infra red (IR) spectrum of 1 exhibited a characteristic absorption at 3109 cm20−1, which32 3 2was also observed for 2 (3107 cm−1), 3 (3111 cm−1), and characteristic absorption at 3109 cm−1, which was also observed for 2 (3107 cm−1), 3 (3111 cm−1), and the other known crambescidin-type analogs [31,33–35]. It was reported that this absorption was due the other known crambescidin-type analogs [31,33–35]. It was reported that this absorption was due to the N-H streching mode of the cyclic guanidine structure [36]. to the N-H streching mode of the cyclic guanidine structure [36]. The 1H and 13C NMR spectra (Tables 1 and 2) showed that 1 consisted of 30 hydrogen and 20 carbon atoms. A hetero-nuclear single quantum coherence (HSQC) experiment indicated that all of the hydrogen atoms were attached to carbons, revealing the presence of five CH, eleven CH2, one CH3, and three C. Two additional protons were observed at δH 10.20 and 10.28 in CDCl3 (Figure S2), supporting the presence of the above-mentioned guanidine moiety characteristic of the crambescidin alkaloids. The signals of the three quaternary carbons were found at δC 85.1 (C-8), 81.3 Mar. Drugs 2018, 16, 84 3 of 13 The 1H and 13C NMR spectra (Tables1 and2) showed that 1 consisted of 30 hydrogen and 20 carbon atoms. A hetero-nuclear single quantum coherence (HSQC) experiment indicated that all of the hydrogen atoms were attached to carbons, revealing the presence of five CH, eleven CH2, one CH3, and three C. Two additional protons were observed at δH 10.20 and 10.28 in CDCl3 (Figure S2), supporting the presence of the above-mentioned guanidine moiety characteristic of the crambescidin alkaloids. The signals of the three quaternary carbons were found at δC 85.1 (C-8), 81.3 (C-15), and 149.4 (C-20). Other NMR signals were characterized as an olefinic bond [δC 134.2/δH 5.50 (C-4) and δC 131.4/δH 5.71 (C-5)], one methyl [δC 10.8/δH 0.84 (C-1)], one oxymethylene [δC 62.6/δH 3.69 (C-19)], one oxymethine [δC 72.1/δH 4.35 (C-3)], two N-subtituted methines [δC 54.9/δH 4.03 (C-10) and δC 53.5/δH 3.96 (C-13)], and ten methylenes (δC 19.5–39.1/δH 1.45–2.59) based on their chemical shifts. These NMR data exhibited a close similarity to those for crambescidin 359 (4)[30], except for the CH2-19 in 1, which is replaced with an ethylidene (CH3-CH<) in 4.